How much revenue did Orion Oyj generate this year?
Orion Oyj has achieved a revenue of 1.4 B EUR this year.
Orion Oyj Revenue 2024
Orion Oyj Revenue
1.4 B EUR
Ticker
ORNBV.HE
ISIN
FI0009014377
WKN
A0J3QM
In 2024, Orion Oyj's sales reached 1.4 B EUR, a 18.01% difference from the 1.19 B EUR sales recorded in the previous year.
The Orion Oyj Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 2.04 | 32,29 |
| 2028e | 1.84 | 35,73 |
| 2027e | 1.72 | 38,22 |
| 2026e | 1.65 | 39,77 |
| 2025e | 1.5 | 43,97 |
| 2024e | 1.4 | 46,85 |
| 2023 | 1.19 | 55,29 |
| 2022 | 1.34 | 63,32 |
| 2021 | 1.04 | 57,01 |
| 2020 | 1.08 | 60,39 |
| 2019 | 1.05 | 60,27 |
| 2018 | 0.98 | 60,32 |
| 2017 | 1.03 | 59,62 |
| 2016 | 1.07 | 60,72 |
| 2015 | 1.02 | 60,04 |
| 2014 | 1.02 | 60,44 |
| 2013 | 1.01 | 60,92 |
| 2012 | 0.98 | 64,30 |
| 2011 | 0.92 | 66,76 |
| 2010 | 0.85 | 66,68 |
| 2009 | 0.77 | 65,63 |
| 2008 | 0.71 | 67,64 |
| 2007 | 0.68 | 67,99 |
| 2006 | 0.64 | 67,99 |
| 2005 | 0.59 | 70,17 |
| 2004 | 0.55 | 68,68 |
Orion Oyj Revenue, EBIT, Net Income FI0009014377 · A0J3QM
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Orion Oyj, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Orion Oyj from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Orion Oyj’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Orion Oyj. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Orion Oyj’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Orion Oyj’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Orion Oyj’s growth potential.
Orion Oyj Revenue, EBIT and net profit per share
| Date | Orion Oyj Revenue | Orion Oyj EBIT | Orion Oyj Net Income |
|---|---|---|---|
| 2029e | 2.04 B undefined | 0 undefined | 345.7 M undefined |
| 2028e | 1.84 B undefined | 479.67 M undefined | 288.55 M undefined |
| 2027e | 1.72 B undefined | 428.83 M undefined | 257.66 M undefined |
| 2026e | 1.65 B undefined | 413.34 M undefined | 247.71 M undefined |
| 2025e | 1.5 B undefined | 330.08 M undefined | 199.61 M undefined |
| 2024e | 1.4 B undefined | 305.55 M undefined | 183.41 M undefined |
| 2023 | 1.19 B undefined | 237.7 M undefined | 216.8 M undefined |
| 2022 | 1.34 B undefined | 438.8 M undefined | 349.5 M undefined |
| 2021 | 1.04 B undefined | 240.3 M undefined | 193.8 M undefined |
| 2020 | 1.08 B undefined | 279.8 M undefined | 219.9 M undefined |
| 2019 | 1.05 B undefined | 253.9 M undefined | 200.4 M undefined |
| 2018 | 977.5 M undefined | 253.1 M undefined | 330.3 M undefined |
| 2017 | 1.03 B undefined | 285.2 M undefined | 226 M undefined |
| 2016 | 1.07 B undefined | 292.9 M undefined | 249 M undefined |
| 2015 | 1.02 B undefined | 269.3 M undefined | 208.2 M undefined |
| 2014 | 1.02 B undefined | 271.9 M undefined | 211.3 M undefined |
| 2013 | 1.01 B undefined | 264.9 M undefined | 206.2 M undefined |
| 2012 | 980.4 M undefined | 280.8 M undefined | 208.9 M undefined |
| 2011 | 917.9 M undefined | 282.6 M undefined | 209.5 M undefined |
| 2010 | 849.9 M undefined | 250 M undefined | 184.7 M undefined |
| 2009 | 771.5 M undefined | 206.7 M undefined | 151.4 M undefined |
| 2008 | 710.7 M undefined | 184.5 M undefined | 136.3 M undefined |
| 2007 | 683.6 M undefined | 194.1 M undefined | 145.5 M undefined |
| 2006 | 641.1 M undefined | 196.8 M undefined | 145.1 M undefined |
| 2005 | 585.6 M undefined | 149.5 M undefined | 113.9 M undefined |
| 2004 | 553 M undefined | 104.4 M undefined | 73.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 553 M EUR | 104.4 M EUR | 73.2 M EUR |
| 2005 | 585.6 M EUR | 149.5 M EUR | 113.9 M EUR |
| 2006 | 641.1 M EUR | 196.8 M EUR | 145.1 M EUR |
| 2007 | 683.6 M EUR | 194.1 M EUR | 145.5 M EUR |
| 2008 | 710.7 M EUR | 184.5 M EUR | 136.3 M EUR |
| 2009 | 771.5 M EUR | 206.7 M EUR | 151.4 M EUR |
| 2010 | 849.9 M EUR | 250 M EUR | 184.7 M EUR |
| 2011 | 917.9 M EUR | 282.6 M EUR | 209.5 M EUR |
| 2012 | 980.4 M EUR | 280.8 M EUR | 208.9 M EUR |
| 2013 | 1.01 B EUR | 264.9 M EUR | 206.2 M EUR |
| 2014 | 1.02 B EUR | 271.9 M EUR | 211.3 M EUR |
| 2015 | 1.02 B EUR | 269.3 M EUR | 208.2 M EUR |
| 2016 | 1.07 B EUR | 292.9 M EUR | 249 M EUR |
| 2017 | 1.03 B EUR | 285.2 M EUR | 226 M EUR |
| 2018 | 977.5 M EUR | 253.1 M EUR | 330.3 M EUR |
| 2019 | 1.05 B EUR | 253.9 M EUR | 200.4 M EUR |
| 2020 | 1.08 B EUR | 279.8 M EUR | 219.9 M EUR |
| 2021 | 1.04 B EUR | 240.3 M EUR | 193.8 M EUR |
| 2022 | 1.34 B EUR | 438.8 M EUR | 349.5 M EUR |
| 2023 | 1.19 B EUR | 237.7 M EUR | 216.8 M EUR |
| 2024e | 1.4 B EUR | 305.55 M EUR | 183.41 M EUR |
| 2025e | 1.5 B EUR | 330.08 M EUR | 199.61 M EUR |
| 2026e | 1.65 B EUR | 413.34 M EUR | 247.71 M EUR |
| 2027e | 1.72 B EUR | 428.83 M EUR | 257.66 M EUR |
| 2028e | 1.84 B EUR | 479.67 M EUR | 288.55 M EUR |
| 2029e | 2.04 B EUR | 0 EUR | 345.7 M EUR |
Orion Oyj stock margins FI0009014377 · A0J3QM
The Orion Oyj margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orion Oyj. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orion Oyj.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Orion Oyj's sales revenue. A higher gross margin percentage indicates that the Orion Oyj retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Orion Oyj's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Orion Oyj's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Orion Oyj's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Orion Oyj. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Orion Oyj's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Orion Oyj Margin History
| Orion Oyj Gross margin | Orion Oyj Profit margin | Orion Oyj EBIT margin | Orion Oyj Profit margin |
|---|---|---|---|
| 2029e | 55.29 % | 0 % | 16.97 % |
| 2028e | 55.29 % | 26.05 % | 15.67 % |
| 2027e | 55.29 % | 24.92 % | 14.97 % |
| 2026e | 55.29 % | 24.99 % | 14.98 % |
| 2025e | 55.29 % | 22.06 % | 13.34 % |
| 2024e | 55.29 % | 21.76 % | 13.06 % |
| 2023 | 55.29 % | 19.98 % | 18.22 % |
| 2022 | 63.32 % | 32.73 % | 26.07 % |
| 2021 | 57.01 % | 23.08 % | 18.62 % |
| 2020 | 60.39 % | 25.95 % | 20.4 % |
| 2019 | 60.27 % | 24.16 % | 19.07 % |
| 2018 | 60.32 % | 25.89 % | 33.79 % |
| 2017 | 59.62 % | 27.59 % | 21.87 % |
| 2016 | 60.72 % | 27.28 % | 23.2 % |
| 2015 | 60.04 % | 26.52 % | 20.5 % |
| 2014 | 60.44 % | 26.78 % | 20.81 % |
| 2013 | 60.92 % | 26.31 % | 20.48 % |
| 2012 | 64.3 % | 28.64 % | 21.31 % |
| 2011 | 66.76 % | 30.79 % | 22.82 % |
| 2010 | 66.68 % | 29.42 % | 21.73 % |
| 2009 | 65.63 % | 26.79 % | 19.62 % |
| 2008 | 67.64 % | 25.96 % | 19.18 % |
| 2007 | 67.99 % | 28.39 % | 21.28 % |
| 2006 | 67.99 % | 30.7 % | 22.63 % |
| 2005 | 70.17 % | 25.53 % | 19.45 % |
| 2004 | 68.68 % | 18.88 % | 13.24 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 68.68 % | 18.88 % | 13.24 % |
| 2005 | 70.17 % | 25.53 % | 19.45 % |
| 2006 | 67.99 % | 30.7 % | 22.63 % |
| 2007 | 67.99 % | 28.39 % | 21.28 % |
| 2008 | 67.64 % | 25.96 % | 19.18 % |
| 2009 | 65.63 % | 26.79 % | 19.62 % |
| 2010 | 66.68 % | 29.42 % | 21.73 % |
| 2011 | 66.76 % | 30.79 % | 22.82 % |
| 2012 | 64.3 % | 28.64 % | 21.31 % |
| 2013 | 60.92 % | 26.31 % | 20.48 % |
| 2014 | 60.44 % | 26.78 % | 20.81 % |
| 2015 | 60.04 % | 26.52 % | 20.5 % |
| 2016 | 60.72 % | 27.28 % | 23.2 % |
| 2017 | 59.62 % | 27.59 % | 21.87 % |
| 2018 | 60.32 % | 25.89 % | 33.79 % |
| 2019 | 60.27 % | 24.16 % | 19.07 % |
| 2020 | 60.39 % | 25.95 % | 20.4 % |
| 2021 | 57.01 % | 23.08 % | 18.62 % |
| 2022 | 63.32 % | 32.73 % | 26.07 % |
| 2023 | 55.29 % | 19.98 % | 18.22 % |
| 2024e | 55.29 % | 21.76 % | 13.06 % |
| 2025e | 55.29 % | 22.06 % | 13.34 % |
| 2026e | 55.29 % | 24.99 % | 14.98 % |
| 2027e | 55.29 % | 24.92 % | 14.97 % |
| 2028e | 55.29 % | 26.05 % | 15.67 % |
| 2029e | 55.29 % | 0 % | 16.97 % |
Orion Oyj Aktienanalyse
What does Orion Oyj do?
Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Orion Oyj's Sales Figures
The sales figures of Orion Oyj originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Orion Oyj’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Orion Oyj's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Orion Oyj’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Orion Oyj Stock
How much was the turnover of the company Orion Oyj compared to the previous year?
The revenue of Orion Oyj has increased by 18.01% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Orion Oyj?
The revenue of Orion Oyj is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Orion Oyj measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Orion Oyj so important for investors?
The revenue of Orion Oyj is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Orion Oyj pay?
Over the past 12 months, Orion Oyj paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 3.86 %. For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.73 EUR.
What is the dividend yield of Orion Oyj?
The current dividend yield of Orion Oyj is 3.86 %.
When does Orion Oyj pay dividends?
Orion Oyj pays a quarterly dividend. This is distributed in the months of April, April, April, November.
How secure is the dividend of Orion Oyj?
Orion Oyj paid dividends every year for the past 23 years.
What is the dividend of Orion Oyj?
For the upcoming 12 months, dividends amounting to 1.73 EUR are expected. This corresponds to a dividend yield of 4.19 %.
In which sector is Orion Oyj located?
Orion Oyj is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orion Oyj from 10/23/2024 amounting to 0.81 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Orion Oyj pay the last dividend?
The last dividend was paid out on 10/23/2024.
What was the dividend of Orion Oyj in the year 2023?
In the year 2023, Orion Oyj distributed 1.5 EUR as dividends.
In which currency does Orion Oyj pay out the dividend?
The dividends of Orion Oyj are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orion Oyj
Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
